Skip to main content
Log in

The significance of biomarkers such as FABP4 in gestational diabetes mellitus and the importance of rigorous peer review

  • Letter to the Editor
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ning H, Tao H, Weng Z, Zhao X (2016) Plasma fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus. Acta Diabetol 53(6):891–898. doi:10.1007/s00592-016-0867-8

    Article  CAS  PubMed  Google Scholar 

  2. Friebe A, Volk HD (2008) Stability of tumor necrosis factor alpha, interleukin 6, and interleukin 8 in blood samples of patients with systemic immune activation. Arch Pathol Lab Med 132(11):1802–1806. doi:10.1043/1543-2165-132.11.1802

    PubMed  Google Scholar 

  3. Li YY, Xiao R, Li CP, Huangfu J, Mao JF (2015) Increased plasma levels of FABP4 and PTEN is associated with more severe insulin resistance in women with gestational diabetes mellitus. Med Sci Monit Int Med J Exp Clin Res 21:426–431. doi:10.12659/MSM.892431

    Google Scholar 

  4. Kralisch S, Stepan H, Kratzsch J, et al (2009) Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Eur J Endocrinol 160(1):33–38. doi:10.1530/EJE-08-0540

    Article  CAS  PubMed  Google Scholar 

  5. Ortega-Senovilla H, Schaefer-Graf U, Meitzner K, et al (2011) Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood. Diabetes Care 34(9):2061–2066. doi:10.2337/dc11-0715

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Magnus Hillman.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Human and animal rights

This article does not contain any studies with human or animal subjects performed by any of the authors.

Informed consent

For this kind of paper formal consent is not applicable.

Additional information

Managed by Massimo Porta.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dereke, J., Hillman, M. The significance of biomarkers such as FABP4 in gestational diabetes mellitus and the importance of rigorous peer review. Acta Diabetol 54, 885–886 (2017). https://doi.org/10.1007/s00592-017-1026-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-017-1026-6

Navigation